Interleukin-2 Receptor Antibody

Company
Ancell Corporation
Use
Antibodies against CD25 for potential use as an immunodirected therapy to selectively attack (kill) CD25 expressing cells
Features
Recognizes epitope B of the IL-2 alpha receptor of about 55 kd (1,6)
NIH Contribution
Discloses a sandwich method and a kit for assaying interleukin-2 receptor (IL-2R) in a sample.
HHS Institute/Agency
NCI
Inventor(s)
R. Yarchoan, W. Leonard, D. Nelson
Year
1999
Tech Cat
Research Reagent

Request More Info

L-117-1997